Editorial: Uncovering Drug Resistance During Cancer Therapy.
作者信息
Wang Haitao, Wang Rui-Hong, Zhou Jian-Guo, Hou Weilong, Wong Ada Hang-Heng
机构信息
Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute (NIH), Bethesda, MA, United States.
Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.
出版信息
Front Genet. 2022 Jul 19;13:945842. doi: 10.3389/fgene.2022.945842. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Uncovering Drug Resistance During Cancer Therapy.社论：癌症治疗期间发现耐药性
Front Genet. 2022 Jul 19;13:945842. doi: 10.3389/fgene.2022.945842. eCollection 2022.
2
Editorial: Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology.社论：临床肿瘤学中基于下一代测序的诊断方法
Front Oncol. 2021 Jan 28;10:635555. doi: 10.3389/fonc.2020.635555. eCollection 2020.
3
From standard to new genome-based therapy of gastric cancer.从胃癌的标准治疗到基于基因组的新疗法。
Expert Rev Gastroenterol Hepatol. 2015;9(8):1023-6. doi: 10.1586/17474124.2015.1060856. Epub 2015 Jun 24.
4
HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China.中国抗逆转录病毒治疗中断期间通过下一代测序检测HIV耐药突变
Pathogens. 2021 Feb 25;10(3):264. doi: 10.3390/pathogens10030264.
5
Next Generation Sequencing Technology in Lung Cancer Diagnosis.下一代测序技术在肺癌诊断中的应用
Biology (Basel). 2021 Sep 3;10(9):864. doi: 10.3390/biology10090864.
6
Editorial: Next-Generation Cancer Therapies Based on a (R)evolution of the Biomarker Landscape.社论：基于生物标志物格局（变革）的新一代癌症疗法
Front Pharmacol. 2022 Mar 7;13:861424. doi: 10.3389/fphar.2022.861424. eCollection 2022.
7
Changing paradigm of cancer therapy: precision medicine by next-generation sequencing.癌症治疗模式的转变：通过下一代测序实现精准医学
Cancer Biol Med. 2016 Mar;13(1):12-8. doi: 10.28092/j.issn.2095-3941.2016.0003.
8
A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.基于下一代测序的临床肿瘤学检测实践之窗。
Arch Pathol Lab Med. 2017 Dec;141(12):1679-1685. doi: 10.5858/arpa.2016-0542-CP. Epub 2017 Oct 13.
9
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms.体外耐药性检测的实施：最大化揭示临床相关耐药机制的潜力。
J Vis Exp. 2015 Dec 9(106):e52879. doi: 10.3791/52879.
10
The emerging roles of NGS in clinical oncology and personalized medicine.NGS 在临床肿瘤学和个性化医学中的新兴作用。
Pathol Res Pract. 2022 Feb;230:153760. doi: 10.1016/j.prp.2022.153760. Epub 2022 Jan 10.
引用本文的文献
1
Immunomodulatory effects of BAFF and APRIL cytokines in post-pulmonary infection lung cancer: Implications for drug resistance and progression.BAFF 和 APRIL 细胞因子在后肺部感染肺癌中的免疫调节作用：对耐药性和进展的影响。
Saudi Med J. 2024 Mar;45(3):223-229. doi: 10.15537/smj.2024.45.3.20230873.
本文引用的文献
1
Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay.乳腺癌耐药性：通过利用微小RNA与肿瘤微环境的相互作用来克服这一挑战
Cancers (Basel). 2021 Jul 22;13(15):3691. doi: 10.3390/cancers13153691.
2
The Two-Faced Role of SIRT6 in Cancer.SIRT6在癌症中的双面角色。
Cancers (Basel). 2021 Mar 8;13(5):1156. doi: 10.3390/cancers13051156.
3
A view on drug resistance in cancer.癌症耐药性的观点。
Nature. 2019 Nov;575(7782):299-309. doi: 10.1038/s41586-019-1730-1. Epub 2019 Nov 13.
4
The role and mechanisms of action of microRNAs in cancer drug resistance.微小 RNA 在癌症药物耐药性中的作用和作用机制。
Clin Epigenetics. 2019 Feb 11;11(1):25. doi: 10.1186/s13148-018-0587-8.
5
Functional Characterization of Human Peptide/Histidine Transporter 1 in Stably Transfected MDCK Cells.人肽/组氨酸转运蛋白 1 在稳定转染的 MDCK 细胞中的功能特征。
Mol Pharm. 2018 Feb 5;15(2):385-393. doi: 10.1021/acs.molpharmaceut.7b00728. Epub 2018 Jan 2.
6
Tumor-associated macrophages: implications in cancer immunotherapy.肿瘤相关巨噬细胞：在癌症免疫治疗中的意义
Immunotherapy. 2017 Mar;9(3):289-302. doi: 10.2217/imt-2016-0135.
7
Myeloid-Derived Suppressor Cells.髓系来源的抑制细胞
Cancer Immunol Res. 2017 Jan;5(1):3-8. doi: 10.1158/2326-6066.CIR-16-0297.
8
The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production.组氨酸转运蛋白 SLC15A4 协调 mTOR 依赖性炎症反应和致病性抗体产生。
Immunity. 2014 Sep 18;41(3):375-388. doi: 10.1016/j.immuni.2014.08.011.
9
The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.mTORC1 通路通过抑制 SIRT4 来刺激谷氨酰胺代谢和细胞增殖。
Cell. 2013 May 9;153(4):840-54. doi: 10.1016/j.cell.2013.04.023.
10
SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism.SIRT4 具有肿瘤抑制活性，并通过抑制线粒体谷氨酰胺代谢来调节细胞对 DNA 损伤的代谢反应。
Cancer Cell. 2013 Apr 15;23(4):450-63. doi: 10.1016/j.ccr.2013.02.024. Epub 2013 Apr 4.
Zotero 插件